The FDA recently approved the anthrax vaccine Cyfendus for adults up to age 65 with suspected or confirmed exposure to Bacillus anthracis, the bacteria that causes anthrax. Several vaccine opponents claim that the approval was “rushed” and misleadingly claim that the vaccine was approved for all people, falsely implying that it will be a routinely administered vaccination.
Recommendation: 
Sign Up for Public Health Alerts
About Us
The Public Health Communications Collaborative (PHCC) was formed in 2020 to coordinate and amplify public health messaging on COVID-19 and increase Americans’ confidence in guidance from the Centers for Disease Control and Prevention (CDC) and state and local public health officials.
Learn More
Learn More